by Leslie Cantu, Medical University of South Carolina Credit: Pixabay/CC0 Public Domain In a new paper published in Cancer Research, researchers at MUSC Hollings Cancer Center have shown that targeting a protein called TACC3 (transforming acidic coiled-coil containing protein 3) can restore the effectiveness of the breast cancer drug T-DM1 if the cancer cells have developed...
by Cardiff University Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Karen Meaburn, Ph.D. at the NIH IRP. Millions of patients with incurable breast cancer could benefit from new Welsh-led research. A clinical...
by Carla K. Johnson This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows production of their Enhertu, an antibody-chemotherapy drug administered intravenously. Credit: Daiichi Sankyo, AstraZeneca via AP For the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very...
